PRESS & MEDIA
LYEONS focuses on advancing brain health through innovative solutions in neuroprotection and sensory modulation. The company works to support individuals affected by stress, anxiety, and trauma by developing tools that may help regulate the autonomic nervous system. Our commitment to scientific research and collaboration is reflected in various media coverage, where stories highlight our technology and the progress we’re making in early intervention and long-term well-being.
-
Are these Cambridge’s next big things?
Cambridge is ranked as No 1 in Europe for unicorns per capital – with 29 unicorns of the UK’s 97 billion dollar companies born in the city. With Cambridge Tech Week in full swing, we highlight 10 Cambridge businesses all vying to be the next big thing.
-
Breakthrough start-ups pitch bold visions for better patient care and outcomes at Accelerate@Babraham demo day
Cambridge NeuroWorks Frontier Fellows presented innovations in stroke rehabilitation, wearable fall prevention and anxiety management, with Lucy Jung focusing on anxiety management.
-
Neurotech Unplugged – Lucy Jung
Lucy Jung joined the latest Neurotech Unplugged session at Imperial College London to discuss the practical realities of building a neurotechnology venture.
-
Cambridge Neurotech Symposium 2026
Lucy Jung, Founder of LYEONS and Charco Neurotech, has invented two neurotech wearables to improve mobility symptoms in Parkinson’s and support autonomic nervous system regulation.
-
CBC Innovation Breakfast: Designing healthcare solutions around real human experience
Healthcare solutions that make a real difference are designed around human experience, observing behaviours, emotions and needs rather than assuming early ideas reflect the true problem. Lucy Jung, Founder of Charco Neurotech and LYEONS, will share how mapping the full patient journey, from early symptoms to long-term management reveals gaps in care and the importance…
-
A Life Science Entrepreneur’s Story: LYEONS
Lucy Jung shares the story behind LYEONS, the neurotech company she founded to develop patient-centred solutions for nervous system regulation. Her journey as a design engineer led to the LYEONS heart, a CE-marked device addressing stress, anxiety and focus through autonomic nervous system regulation.
-
Pioneering Progress: An interview with Lucy Jung on the impact of Cambridge NeuroWorks
Lucy Jung drew from her own experiences to build her startup LYEONS Neurotech through Cambridge NeuroWorks’ Frontier Fellowship. The fellowship’s community accelerated her research and connected her with collaborators.
-
Scaling Neurotech: Innovation, Investment and Better Brain Function
What if we could enhance the way our brains learn, heal, and adapt – responsibly? Neurotechnology is rapidly redefining how we understand and interact with the human brain, raising both exciting possibilities and important ethical and policy considerations.
-
Pitch @ Judge – Winter 2025 winners
Cambridge Judge Business School lists Lucy Jung and LYEONS among the winners of its Winter 2025 Pitch @ Judge competition. Many congratulations to Dequn Teng – LLMVentures and Anton Petrov – Riboscope Bio too.
-
Beta Launch of LYEONS Heart
Cambridge Network features the beta launch of 23 LYEONS Heart devices, describing the handheld wellness device, its community-led beta programme and the role of early-user feedback in shaping the next stage of development.